In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
Dileep R. Yavagal, MD, Professor of Neurology & Neurosurgery and Chief Interventional Neurologist at the University of Miami – Miller School of Medicine, describes a treatment that has…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate infusions may not help patients with acute aneurysmal subarachnoid hemorrhage, according to a study published in the August issue of…
NEW YORK (Reuters Health) – By evaluating risk factors for thromboembolism, physicians can reduce the number of computed tomography (CT) angiograms they order for patients with suspected pulmonary…
NEW YORK (Reuters Health) – Nine times out of 10, patients admitted to a U.S. hospital for acute exacerbation of chronic obstructive pulmonary disease (COPD) are treated initially…
NEW YORK (Reuters Health) – Incidental findings on brain magnetic resonance imaging (MRI) scans are seen in a significant minority of children, although most of these findings are…
NEW YORK (Reuters Health) – The novel antiarrhythmic agent vernakalant is a safe and effective agent for pharmacologic conversion of recent-onset atrial fibrillation (AF) in hemodynamically stable patients,…
NEW YORK (Reuters Health) – Nonintravenous midazolam (Versed) is better at ending status epilepticus than diazepam (Valium) in children and young adults, and is just as safe, according…
NEW YORK (Reuters Health) – Inhaled anticholinergics may increase the risk of community-acquired pneumonia in asthma patients, results of a Spanish case-control study suggest. The findings, published online…
NEW YORK (Reuters Health) – Propofol may be preferable to ketamine for procedural sedation in the emergency department, researchers conclude in a study published online June 2 in…
NEW YORK (Reuters Health) – More than half of elderly patients who come out of the hospital after pneumonia either die within a year or get readmitted for…
NEW YORK (Reuters Health) – In patients with extensively drug-resistant tuberculosis (XDR TB), adding a later-generation fluoroquinolone to the treatment regimen may improve outcomes, even when drug-susceptibility testing…
